CompletedNot Applicable

Evaluation of Hepatic Rigidity by Ultrasonic Impulse Elastography in Liver Transplant Patients

France63 participantsStarted 2017-06-27

Plain-language summary

Interventional study with minimal risks and constraints, prospective, mono-centric.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men and women aged 18 years and over ; * Hepatic transplant patient attending a day hospital of hepatology as part of the systematic follow-up of liver transplantation at 1 year, 5 years or 10 years in order to benefit from a clinical examination, biological evaluation, hepatic ultrasound, Fibroscan and Hepatic Puncture-Biopsy ; * Patient in a position to receive information about the protocol ; * Patient having given his / her written consent. Exclusion Criteria: * Coagulation disorder (platelets \<60,000, Prothrombin Ratio \<50%, partial thromboplastin time \> 1.5 times the control unless explained by insufficient factor XII deficiency or anti-phospholipid antibodies); * Ascites; * Platelet antiaggregation taken the previous week biopsy, patient under anticoagulants; * Persons of full age who are subject to legal protection (safeguard of justice, guardianship, guardianship), persons deprived of their liberty; * Patient not affiliated to social security; * Pregnant or nursing women; * Simultaneous participation in another research.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Hepatic graft stiffness in kPa without complication

Timeframe: Baseline

Trial details

NCT IDNCT03174327

SponsorRennes University Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-04-24

View on ClinicalTrials.gov More Hepatic Transplantation trials